NATASHA BARAUSKAS: Open Payments
NPI 1407527914 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$191 in 7 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $247 · 2025 $191
Food & beverage: $165Education: $26
| Company | Payments | Amount |
|---|---|---|
| Eurofins Viracor, LLC | 1 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Veloxis Pharmaceuticals, Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Alexion Pharmaceuticals, Inc. | 1 | $18 |
Products named: FARXIGA, ENVARSUS, PREVYMIS, ULTOMIRIS.
Industry payments across WA — which companies pay providers there.
